ASTRAZENECA PHARMA INDIA
Back to All Ratios
|
ASTRAZENECA PHARMA INDIA Last 5 Year Price to Cash Earnings (PCE) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 138.16 | 75.38 | 70.26 | 81.33 | 66.34 |
What is the latest Price to Cash Earnings (PCE) ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 138.16 |
| Mar2024 | 75.38 |
| Mar2023 | 70.26 |
| Mar2022 | 81.33 |
| Mar2021 | 66.34 |
How is Price to Cash Earnings (PCE) of ASTRAZENECA PHARMA INDIA Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 138.16 | 83.28 | |
| Mar2024 | 75.38 | 7.29 | |
| Mar2023 | 70.26 | -13.61 | |
| Mar2022 | 81.33 | 22.60 | |
| Mar2021 | 66.34 | - | |
Other Financial Ratios of ASTRAZENECA PHARMA INDIA
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹19,865.3 Cr | -4.3% | -9.6% | -1.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -4.3% |
-9.6% |
-1.2% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses